anticoagulant

• European Union
• Germany
• Healthcare
• Pharma & Biotech
• Science

Boehringer Ingelheim: EU grants marketing authorisation for Giotrif® for the treatment of patients with advanced squamous cell carcinoma (SqCC) of the lung

• Approval provides a new oral treatment option for patients with the second largest sub-type of non-small cell lung cancer…